Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksCONCORD
resources
CONCORD

Concord Drugs Ltd.

BSE: 538965
Sector: Healthcare
Industry: Pharmaceuticals
69.00+1.0 (+1.47%)
22 Oct, 12:00 AM

Annual Reports and Financial Documents

Concord Drugs Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
2013201420162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Quarterly Results————
Conference Calls—————————————
Presentations—————————————

Corporate Announcements and Regulatory Filings

Concord Drugs Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. AGM1 Oct 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Annual general meeting -Scrutinizer''s Report
  2. AGM30 Sept 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Summary Proceedings of AGM
  3. Closure of Trading Window25 Sept 2026
    Closure of Trading Window
    Closure of trading Window
  4. Newspaper Publication9 Sept 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Copies of News paper publications of the Notice of the 31st AGM to be held on 30.09.2026
  5. General7 Sept 2026
    Letter To Shareholders
    Letter to members as per regulation 36(1)(b)
  6. Record Date7 Sept 2026
    Intimation Of Record Date For 31St AGM
    Record date for Annual general meeting
  7. Book Closure7 Sept 2026
    31St AGM
    Book Closure for AGM to be held on 30.09.2026
  8. Reg. 34 (1) Annual Report7 Sept 2026
    Reg. 34 (1) Annual Report.
    31st Annual Report of the Company
  9. AGM7 Sept 2026
    31St Annual General Meeting
    AGM to be held on 30.09.2026 at 09:00 AM
  10. Outcome without intimation7 Sept 2026
    Board Meeting Outcome for Annual General Meeting To Be Held On 30.09.2026
    Company has approved the notice and proposed to hold 31st AGM on 30.09.2026
  11. Newspaper Publication12 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Copy of News-paper publications for quarterly results ended 30th June 2026.
  12. Outcome of Board Meeting10 Aug 2026
    Board Meeting Outcome for Outcome Of Board Meeting
    Outcome of Board meeting
  13. Board Meeting3 Aug 2026
    Board Meeting Intimation for Quarterly Results
    Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve Quarterly Results
  14. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201813 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Reg 74(5) of SEBI (DP) Regulations
  15. Closure of Trading Window25 Jun 2026
    Closure of Trading Window
    Closure of Trading Window
  16. Newspaper Publication1 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Copy of Newspaper publication for audited results for year ended 31st March,2026.
  17. Reg.24(A)-Annual Secretarial Compliance29 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Annual Secretarial Compliance report under Regulation 24(A)
  18. Outcome of Board Meeting27 May 2026
    Board Meeting Outcome for Approval Of Financial Results
    Company has approved financial results for Quarter and year ending 31st March,2026
  19. Board Meeting18 May 2026
    Board Meeting Intimation for Audited Results For Year Ending 31.03.2026
    Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve Financial Results for year ending 31.03.2026
  20. Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A6 May 2026
    Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
    <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....

Frequently Asked Questions

Where can I download the annual report of Concord Drugs Ltd.?
Annual reports of Concord Drugs Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Concord Drugs Ltd.?
Quarterly earnings results and presentations of Concord Drugs Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Concord Drugs Ltd. publish earnings call transcripts?
Earnings call transcripts of Concord Drugs Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Concord Drugs Ltd.?
Investor presentations and annual day presentations of Concord Drugs Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Concord Drugs Ltd.?
Corporate announcements and regulatory filings of Concord Drugs Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Concord Drugs Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Concord Drugs Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Concord Drugs Ltd.?
The ISIN (International Securities Identification Number) of Concord Drugs Ltd. is INE858L01010. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Concord Drugs Ltd. listed?
Concord Drugs Ltd. is listed on NSE and BSE. The NSE symbol is CONCORD and the BSE code is -.
Where can I find the shareholding pattern of Concord Drugs Ltd.?
The quarterly shareholding pattern of Concord Drugs Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Concord Drugs Ltd. on Sharpely?
Share price data for Concord Drugs Ltd. is updated as of 22 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.